Vectron Biosolutions AS is your expert on developing cost-effective microbial production processes for recombinant proteins

Do you need to cut manufacturing costs?

The manufacturing costs of many recombinant proteins can be significantly reduced through increasing titres and improving the solubility of the proteins, reducing the necessities of costly downstream processes. This is increasingly important in the competitive landscape of the biopharmaceutical industry, especially with the advent of biosimilars and biobetters, as well as for suppliers of industrial enzymes where the markets are smaller.

Vectron Biosolutions is your upstream expert on developing robust, cost-efficient production processes for recombinant proteins in E. coli and other bacteria. We have proprietary next-generation expression tools and decades of experience that is available to you through partnerships and licensing.

Latest news

  • Vectron is featured in Dagens Næringsliv

    July 24 | 2018

    Vectron Biosolution was featured in Dagens Næringsliv on July 24, as one of the most interesting biotech startups in Norway.

  • VIVO career day at NTNU

    March 06 | 2018

    Vectron Biosolutions participated on this year's VIVO career day at NTNU

    Read more
  • Gold Medal

    November 20 | 2017

    The NTNU iGEM 2017 team wins Gold Medal in Boston.

    Read more
  • In memoriam: Svein Valla

    September 18 | 2017

    Professor Svein Valla, founder of Vectron, passed away September 13.

    Read more
Complete newslist


  • PEGS Europe Protein and Antibody Engineering Summit Lisbon, Portugal

    Nov 12–16 | 2018
  • PepTalk: The Protein Science Week, San Diego, CA, USA

    Jan 14–18 | 2019
  • BIO-Europe Spring, Vienna, Austria

    Mar 25–27 | 2019
Meet us there!
More events